Citadel Advisors »

Chemomab Therapeutics shares owned by Citadel Advisors

Quarter-by-quarter ownership of Chemomab Therapeutics (CMMB) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Chemomab Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Chemomab Therapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Chemomab Therapeutics by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $17k 33k 0.51

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Tesla Motors Call Option (TSLA)
NVIDIA Corporation Call Option (NVDA)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Microsoft Corporation Call Option (MSFT)
Meta Platforms Cl A Call Option (META)
Apple Call Option (AAPL)
Amazon Call Option (AMZN)
Ishares Tr Iboxx Hi Yd Etf Call Option (HYG)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Advanced Micro Devices Call Option (AMD)
Netflix Call Option (NFLX)
Alphabet Cap Stk Cl C Call Option (GOOG)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Chemomab Therapeutics

OrbiMed Advisors
Ikarian Capital
Two Sigma Investments
Two Sigma Advisers
Citadel Advisors
Kestra Private Wealth Services
Virtu Financial
Millennium Management
Rhumbline Advisers
Advisor Group Holdings
Moser Wealth Advisors

View all funds holding Chemomab Therapeutics